Wong D - Search Results

1

Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis.

Sharma SA, Kowgier M, Hansen BE, Brouwer WP, Maan R, Wong D, Shah H, Khalili K, Yim C, Heathcote EJ, Janssen HLA, Sherman M, Hirschfield GM, Feld JJ. Sharma SA, et al. Among authors: wong d. J Hepatol. 2017 Aug 24:S0168-8278(17)32248-1. doi: 10.1016/j.jhep.2017.07.033. Online ahead of print. J Hepatol. 2017. PMID: 28844936

2

Interferon alfa treatment of chronic hepatitis B: randomized trial in a predominantly homosexual male population.

Wong DK, Yim C, Naylor CD, Chen E, Sherman M, Vas S, Wanless IR, Read S, Li H, Heathcote EJ. Wong DK, et al. Gastroenterology. 1995 Jan;108(1):165-71. doi: 10.1016/0016-5085(95)90021-7. Gastroenterology. 1995. PMID: 7806038 Clinical Trial.

3

Long-term follow-up of a randomized trial of interferon therapy for chronic hepatitis B in a predominantly homosexual male population.

Chen DK, Yim C, O'Rourke K, Krajden M, Wong DK, Heathcote EJ. Chen DK, et al. Among authors: wong dk. J Hepatol. 1999 Apr;30(4):557-63. doi: 10.1016/s0168-8278(99)80184-6. J Hepatol. 1999. PMID: 10207795 Clinical Trial.

4

Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirin.

Sherman M, Cohen L, Cooper MA, Elkashab M, Feinman V, Fletcher D, Girgrah N, Heathcote J, Levstik M, McNaull WB, Wong D, Wong F, Yim C. Sherman M, et al. Among authors: wong d, wong f. Can J Gastroenterol. 2006 Jul;20(7):479-85. doi: 10.1155/2006/497059. Can J Gastroenterol. 2006. PMID: 16858501 Free PMC article. Review.

5

Endpoints of therapy in chronic hepatitis B.

Feld JJ, Wong DK, Heathcote EJ. Feld JJ, et al. Hepatology. 2009 May;49(5 Suppl):S96-S102. doi: 10.1002/hep.22977. Hepatology. 2009. PMID: 19399800

6

Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C.

Pattullo V, Ravindran NC, Mazzulli T, Wong DK, Heathcote EJ. Pattullo V, et al. Among authors: wong dk. J Viral Hepat. 2010 Dec;17(12):834-8. doi: 10.1111/j.1365-2893.2010.01248.x. J Viral Hepat. 2010. PMID: 20196800

7

Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.

Woo G, Tomlinson G, Nishikawa Y, Kowgier M, Sherman M, Wong DK, Pham B, Ungar WJ, Einarson TR, Heathcote EJ, Krahn M. Woo G, et al. Gastroenterology. 2010 Oct;139(4):1218-29. doi: 10.1053/j.gastro.2010.06.042. Epub 2010 Jun 20. Gastroenterology. 2010. PMID: 20600036 Review.

8

Superior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C.

Pattullo V, Heathcote EJ, Wong DK. Pattullo V, et al. Hepatol Int. 2010 Aug 8;4(4):723-31. doi: 10.1007/s12072-010-9207-1. Hepatol Int. 2010. PMID: 21286343 Free PMC article.

9

Non-alcoholic fatty liver disease in HIV infection associated with altered hepatic fatty acid composition.

Arendt BM, Mohammed SS, Ma DW, Aghdassi E, Salit IE, Wong DK, Guindi M, Sherman M, Heathcote EJ, Allard JP. Arendt BM, et al. Curr HIV Res. 2011 Mar;9(2):128-35. doi: 10.2174/157016211795569140. Curr HIV Res. 2011. PMID: 21434863

10

Hepatitis B learning needs assessment of family medicine trainees in Canada: results of a nationwide survey.

Sam JJ, Heathcote EJ, Wong DKh, Wooster DL, Shah H. Sam JJ, et al. Can J Gastroenterol. 2011 Mar;25(3):127-34. doi: 10.1155/2011/957937. Can J Gastroenterol. 2011. PMID: 21499576 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,324 results

Search Page

Filters